Cargando…

High density of CD204‐positive macrophages predicts worse clinical prognosis in patients with breast cancer

Recent studies have indicated the clinical significance of tumor‐associated macrophages (TAM) in several malignant tumors including breast cancer. Although recent studies have focused on CD68‐positive or CD163‐positive TAM in breast cancer, no study has investigated the significance of CD204‐positiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyasato, Yuko, Shiota, Takuya, Ohnishi, Koji, Pan, Cheng, Yano, Hiromu, Horlad, Hasita, Yamamoto, Yutaka, Yamamoto‐Ibusuki, Mutsuko, Iwase, Hirotaka, Takeya, Motohiro, Komohara, Yoshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543503/ https://www.ncbi.nlm.nih.gov/pubmed/28574667 http://dx.doi.org/10.1111/cas.13287

Ejemplares similares

The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer
por: Shiota, Takuya, et al.
Publicado: (2016)

An IL‐27/Stat3 axis induces expression of programmed cell death 1 ligands (PD‐L1/2) on infiltrating macrophages in lymphoma
por: Horlad, Hasita, et al.
Publicado: (2016)

GM-CSF derived from the inflammatory microenvironment potentially enhanced PD-L1 expression on tumor-associated macrophages in human breast cancer
por: Yonemitsu, Kimihiro, et al.
Publicado: (2022)

CD163 deficiency facilitates lipopolysaccharide‐induced inflammatory responses and endotoxin shock in mice
por: Fujiwara, Yukio, et al.
Publicado: (2020)

A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer
por: Yamamoto, Satoko, et al.
Publicado: (2013)

Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes
por: Komohara, Yoshihiro, et al.
Publicado: (2023)

Possible functions of CD169‐positive sinus macrophages in lymph nodes in anti‐tumor immune responses
por: Komohara, Yoshihiro, et al.
Publicado: (2017)

Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence
por: Sueta, Aiko, et al.
Publicado: (2017)

Overexpression of CD163, CD204 and CD206 on Alveolar Macrophages in the Lungs of Patients with Severe Chronic Obstructive Pulmonary Disease
por: Kaku, Yoichiro, et al.
Publicado: (2014)

An Integrative Analysis of PIK3CA Mutation, PTEN, and INPP4B Expression in Terms of Trastuzumab Efficacy in HER2-Positive Breast Cancer
por: Sueta, Aiko, et al.
Publicado: (2014)

Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer
por: Takeshita, Takashi, et al.
Publicado: (2018)

Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy
por: Yano, Hiromu, et al.
Publicado: (2022)

Oligodendrocyte Progenitor Cells and Macrophages/Microglia Produce Glioma Stem Cell Niches at the Tumor Border
por: Hide, Takuichiro, et al.
Publicado: (2018)

BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study
por: Kosaka, Yoshimasa, et al.
Publicado: (2020)

Prognostic role of PIK3CA mutations of cell‐free DNA in early‐stage triple negative breast cancer
por: Takeshita, Takashi, et al.
Publicado: (2015)

Associations Between Elastography Findings and Clinicopathological Factors in Breast Cancer
por: Hayashi, Mitsuhiro, et al.
Publicado: (2015)

Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients
por: Takeshita, Takashi, et al.
Publicado: (2016)

Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients
por: Takeshita, Takashi, et al.
Publicado: (2017)

Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients
por: Takeshita, Takashi, et al.
Publicado: (2017)

Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer
por: Suyama, Koichi, et al.
Publicado: (2017)

Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients
por: Takeshita, Takashi, et al.
Publicado: (2017)

Flavonoid Compounds Contained in Epimedii Herba Inhibit Tumor Progression by Suppressing STAT3 Activation in the Tumor Microenvironment
por: Pan, Cheng, et al.
Publicado: (2020)

Onionin A inhibits ovarian cancer progression by suppressing cancer cell proliferation and the protumour function of macrophages
por: Tsuboki, Junko, et al.
Publicado: (2016)

PTIP Associated protein 1, PA1, Is an Independent Prognostic Factor for Lymphnode Negative Breast Cancer
por: Takeshita, Takashi, et al.
Publicado: (2013)

APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer
por: Fujiki, Yoshitaka, et al.
Publicado: (2018)

Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy
por: Omoto, Yoko, et al.
Publicado: (2015)

GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development
por: Kuwahara, Kazuhiko, et al.
Publicado: (2016)

Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer
por: Yamamoto, Yutaka, et al.
Publicado: (2013)

Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival
por: Rezano, Andri, et al.
Publicado: (2013)

Prognostic significance of CD169‐positive lymph node sinus macrophages in patients with endometrial carcinoma
por: Ohnishi, Koji, et al.
Publicado: (2016)

Guanylate-binding protein 5 is a marker of interferon-γ-induced classically activated macrophages
por: Fujiwara, Yukio, et al.
Publicado: (2016)

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
por: Okumura, Yasuhiro, et al.
Publicado: (2008)

Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer
por: Tomiguchi, Mai, et al.
Publicado: (2016)

CD169‐positive sinus macrophages in the lymph nodes determine bladder cancer prognosis
por: Asano, Touko, et al.
Publicado: (2018)

A Novel Strategy for Inducing the Antitumor Effects of Triterpenoid Compounds: Blocking the Protumoral Functions of Tumor-Associated Macrophages via STAT3 Inhibition
por: Fujiwara, Yukio, et al.
Publicado: (2014)

Clinical significance of macrophage heterogeneity in human malignant tumors
por: Komohara, Yoshihiro, et al.
Publicado: (2014)

Safety and adverse effects of the coronavirus disease 2019 vaccine among the general Japanese adult population
por: Lu, Xi, et al.
Publicado: (2023)

Maf expression in human macrophages and lymph node sinus macrophages in patients with esophageal cancer
por: Takeya, Hiroto, et al.
Publicado: (2019)

Cholesterol metabolism and lipid droplet vacuoles; a potential target for the therapy of aggressive lymphoma
por: Yano, Hiromu, et al.
Publicado: (2022)

Targeted therapies for ER+/HER2- metastatic breast cancer
por: Yamamoto-Ibusuki, Mutsuko, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vfdf9sd9punp23q9culq2p3rt1